Ornithine decarboxylase (ODC), the first enzyme of polyamine biosynthesis, was found to increase in cancer cells, especially prostate cancers. Some chemotherapeutic agents aimed to decrease ODC expression showed inhibitory effects on cancer cells. In this study, we examined the effect of adenoviraltransduced antisense ODC on prostate cancer cells. An adenovirus carrying antisense ODC (rAd-ODC/Ex3as) was infected to prostate cancer cells PC-3 and LNCap. Expression of ODC and concentration of polyamines in cells were determined by Western blotting and HPLC. MTT (3-(4,5-methylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide) assay was used to analyze the effect on cell growth. Cell cycle was evaluated by FCM and cellular invasion by Matrigel invasion assay. A nude mouse xenograft model was used to examine tumorigenicity. Expression of ODC in PC-3 and LNCap cells were reduced to 45 and 59%, and three polyamines were also decreased by the rAd-ODC/Ex3as treatment. Consequently, cell growth was substantially inhibited and cell cycle arrested at G1 phase. Matrigel invasion assay showed relatively low invasion. Marked suppression of tumor formation was observed in the xenograft model. This study suggests that rAd-ODC/Ex3as has the antitumor effect on the human prostate cancer cells.
Introduction
The polyamines, spermidine, spermine and the diamine precursor, putrescine, are positively charged aliphatic amines at physiological conditions, have a low-molecular weight and a simple chemical structure. They interact with various macromolecules, both electrostatically and covalently, and, as a consequence, have a variety of cellular effects. They are known to be critically involved in cell growth and have been implicated in the process of cell transformation. 1, 2 On the other hand, the level of polyamine is high in cancer cell and tissues, and rapid tumor growth has been associated with remarkable elevation of polyamine biosynthesis and accumulation. 3, 4 Ornithine decarboxylase (ODC) is the first and the rate-controlling enzyme in polyamine biosynthesis. It decarboxylates L-ornithine to form diamine putrescine. Complete structure and nucleotide sequence of ODC gene from mammalians is known for human, 5 which have 12 exons and 11 introns. Active mammalian ODC is a homodimer with two-fold symmetry. Subunits have molecular weight of about 51 kDa and the polypeptide chain consists of 461 amino acids. ODC becomes activated after treatment with chemical carcinogens and tumor promoters, as well as in cells transformed by various oncogenes such as v-src, neu and ras. [6] [7] [8] The level of ODC was reportedly elevated in various cancers [9] [10] [11] and related to recurrence. 12 Some chemotherapeutic agents, such as DFMO, which aimed to inhibit the activity of ODC have appeared and taken on inhibitory effects on tumor growth in vitro and in vivo, 13, 14 although showing dose-limiting toxicity. Stable transfection of human lung squamous carcinoma cell line LTEP-78 with antisense ODC-expressing plasmid DNA has been shown to be related with the reversion of malignant phenotypes of human lung squamous carcinoma cells. 15 Taken together, these findings suggest that ODC may provide an important target for the development of agents that inhibit carcinogenesis and tumor growth.
Prostate cancer is the most frequently diagnosed cancer in men. Metastatic prostate cancer is essentially resistant to systemic cytotoxic chemotherapy, while external beam and radioisotope radiotherapy offers only symptom palliation. Clearly, the development of novel therapies, such as gene therapy, is a high priority. Some studies had proved that the prostate gland had almost the highest level of polyamines in the body and prostate carcinomas had even greater elevated polyamine levels. 9 In our earlier studies on human prostate disease, we also proved that expression of ODC was greater in the benign prostatic hyperplasia (BPH) than in normal prostate tissues. 16 Adenoviral vectors are among the most promising gene transfer vehicles for direct, in vivo gene therapy for the treatment of a diverse array of human disease. 17 In this study, we used a replication-deficient recombinant adenovirus to deliver efficiently a 120 bp antisense ODC, which is complementary to initiation codon and tested the effect of antisense ODC on prostate cancer. The data presented here show that adenovirusmediated gene transfer of antisense ODC could significantly inhibit growth and invasion of prostate cancer cells and lower the tumorigenicity of prostate cancer cells in nude mice.
Materials and methods
Cell culture and reagents PC-3 and LNCap human prostate cancer cell lines were preserved in our lab. HE293 cell line was obtained from Chinese Academy of Sciences. Cells were cultured in DMEM or RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS), 100 U/ml penicillin and 100 mg/ml streptomycin. MTT (3-(4,5-methylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide), putrescine, spermidine and spermine were purchased from Sigma, MO, USA. b-Actin antibody and ECL Western blotting detection system were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Monoclonal antibody of ODC was made in our lab. Matrigel and transwell inserts were purchased from BD Bioscience (Bedford, MA, USA) and Costar (Cambridge, MA, USA). Other reagents were all of reagent grade and obtained from Chinese companies.
Adenovirus and infection condition
The recombinant adenovirus rAd-ODC/Ex3as, containing the cytomegalovirus (CMV) promoter and GFP gene, was constructed by reversely inserting a 120 bp cDNA fragment of ODC into the multiple clone sites. 18 rAd-ODC/Ex3as was purified by ultracentrifugation in cesium chloride step gradients. 19 The titer of the viral stock, measured in plaque-forming unit (PFU)/ml, was determined to be 8.5 Â 10 9 PFU/ml by a method published previously, 20 and the frozen stock was confirmed to have retained their titer. The control virus rAd-GFP was same to rAd-ODC/Ex3as, but no gene inserted in the polylinker. Viral stocks were suitably diluted in serum-free medium to obtain the desired PFU, added to cell monolayers of prostate cancer cells and incubated at 371C for 2 h. The necessary amount of culture medium with 5% FBS was then added and the cells were incubated for the desired times.
MTT assay
Firstly, MTT assay was employed to assess transduction efficiency of rAd-ODC/Ex3as in PC-3 and LNCap cell lines. Briefly, both cells were seeded at density of 5000 cells/well in 96-well plates and grown overnight. On the next day, the cells were infected by a wide range of viral titres, from 1 to 100 PFU/cell (MOI, multiplicity of infection). After 48 h of incubation, MTT was added (50 mg/well) for 4 h. Formazan products were solubilized with DSMO, and the optical density was measured at 570 nm.
To observe the effect of adenovirus on cell proliferation, MTT assay was also used to draw cell growth curves. Cells were inoculated at a density of 4000 cells/ well, under which control cells remained subconfluent and in exponential growth phase for the duration of the assay. Owing to different infective efficiency, PC-3 cell and LNCap cells were infected by 50 and 25 MOI, respectively. All experiments were performed in sextuple. After 24, 48, 72, 96 and 120 h, cell viability was measured by absorbance at 570 nm as described previously.
Western blotting analysis of ODC proteins
PC-3 cells and LNCap cells were infected with rAd-ODC/Ex3as by 50 and 25 MOI in 1640 medium containing 5% FCS for 48 h. The cells were washed three times with ice-cold PBS and collected with a cell scraper. Total cell lysates were prepared in extraction buffer containing 0.05 M Tris (pH 8.0), 0.15 M NaCl, 0.02% sodium azide, 0.1% SDS, 100 mg/ml PMSF (phenylmethylsulfonyl fluoride), 1 mg/ml aprotinin and 1% NP-40. The extracts were subjected to 12% SDS-PAGE and transferred to a nitrocellulose membrane. The membrane was blocked for 1 h at room temperature in PBS containing 1% powdered milk. Mouse anti-ODC monoclonal antibody was added at a dilution of 1/500 and incubation was continued overnight at 41C. The secondary antibody was horseradish peroxidase-conjugated antimouse IgG antibody (Zhongshan, Beijing, China). Antibody reactive bands were revealed using the ECL Western blotting detection system (Santa Cruz, CA, USA). The content of each protein sample was controlled by means of b-actin. For quantitation of bands, we used Nikon digital camera and SmartView analysis software.
HPLC analysis of polyamine pools
PC-3 and LNCap cells were infected with rAd-ODC/ Ex3as at an MOI of 50 and 25. After 48 h, cells were trypsinized and washed with PBS twice. Intracellular polyamine were extracted from cell pellets with 10% trichloroacetic acid, dansylated and measured by reverse-phase HPLC as described previously. 21 Antisense ODC adenovirus and prostate cancer Y Zhang et al
Flow cytometry analysis
For flow cytometry analysis, rAd-ODC/Ex3as infected PC-3 cells and LNCap cells at an MOI of 50 and 25. After 48 h, the cells were washed with PBS twice and harvested by trypsinization. The cells were washed again with PBS and fixed with cold 70% ethanol for 1 h. Cells were washed with PBS once and then incubated with 4 mg of ribonuclease A (Roche) for 30 min at room temperature. Propidium iodide was added to the cell suspension at a final concentration of 20 mg/ml and incubated for 30 min. Cells were then analyzed by flow cytometry using FACScan (Becton Dickinson). The results were quantified by using the software Cell Quest (Becton Dickinson).
Matrigel invasion assay
Invasion was assessed by the ability of PC-3 cells infected with rAd-ODC/Ex3as to traverse a Matrigel-coated membrane as follows. Transwell inserts (8 mm pore size, Costar) for six-well culture plates were coated with a final concentration of 0.7 mg/ml Matrigel (Becton Dickinson, Bedford, MA, USA). Cells were trypsinized, and 1.5 ml of cell suspension (5 Â 10 5 cells/ml) were added in triplicate wells. The lower chamber was filled with 1640 medium containing 10% FCS. These chambers were incubated for 6 h at 371C with 5% CO 2 to allow cells to migrate through the matrigel-coated membranes. The nonmigrated cells were scraped from the upper surface of the membrane with cotton swabs. Cells on the bottom side of the membrane were fixed and stained with HE. Five representative fields in each well were counted under the microscope at Â 40 magnification to determine the number of migrated cells.
Nude mouse tumorigenicity study
The PC-3 cells were infected with rAd-ODC/Ex3as at an MOI of 50 for 48 h, harvested, washed three times with PBS and resuspended in 1640 medium. The cell suspensions (2 Â 10 6 ) in a total volume of 100 ml were then injected subcutaneously into 6-week-old BALB/C nude male mice. Tumor volume was measured every week and calculated with the following formula: volume ¼ M1 Â M2 Â M2 Â 0.5236 (M1, long axis; M2, short axis), according to Rockwell et al.
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Statistical analysis
Statistical analysis was examined by Mann-Whitney's U-test.
Results
Inhibition effect of rAd-ODC/Ex3as on prostate cancer cells
There was dose-dependent growth inhibition in both PC-3 and LNCap cell lines, which reflected the transduction efficiency of the adenovirus to different cell line of prostate cancer cells. LNCap cell line was more sensitive to infection of rAd-ODC/Ex3as (Figure 1a and b) . Owing to differential sensitivity of various cell lines, we chose 50 and 25 MOI of adenovirus to infect PC-3 and LNCap cells. Under these conditions, rAd-ODC/Ex3as was more suppressive of growth than the control rAd-GFP virus, while rAd-GFP had no obviously toxic effect on cells. We examined the in vitro growth inhibition of rAd-ODC/ Ex3as in PC-3 and LNCap cells using cell growth curves as described in 'Material and methods'. Antisense ODC had an impact on the growth of prostate cancer cells. rAd-ODC/Ex3as in both cells inhibited their proliferation by B50% when compared with the control virusand no virus-treated groups (Figure 1c and d) .
Effect of rAd-ODC/Ex3as on expression of the ODC and polyamine pools in the cell lysate
The ODC proteins produced from the PC-3 and LNCap cells after infection with rAd-ODC/Ex3as were examined by Western immunoblot analysis. The ODC expression in the cells infected with rAd-ODC/Ex3as was substantially more reduced than in the cells infected with rAd-GFP or no virus-treated cells. The results analyzed by SmartView software showed that ODC expression in PC-3 cells infected with rAd-ODC/Ex3as accounted for 45% of that in cells treated with rAd-GFP. In the case of LNCap cells, the number was 59% (Figure 2) . HPLC also exhibited a decrease of concentrations of the three polyamines, especially of putrescine (Table 1) .
rAd-ODC/Ex3as infection induced cell cycle arrest at G1 phase
To examine the mechanism by which rAd-ODC/Ex3as may retard prostate cancer cell growth in vitro, the cell cycle was analyzed using flow cytometry to assess cell cycle kinetics in PC-3 and LNCap cells 48 h after infection ( Figure 3 ). As shown in Table 2 , the proportion of cells in G1 increased significantly in rAd-ODC/Ex3as-infected cells in comparison to rAd-GFP-infected or no virus-treated cells.
rAd-ODC/Ex3as infection decreased invasion of PC-3 cells
We used Matrigel invasion model to study the effect of the rAd-ODC/Ex3as on invasion. PC-3 cells infected with rAd-ODC/Ex3as (19.478.79) invaded Matrigelcoated membrane to a much lesser extent than rAd-GFP-infected cells (35.478.82) or no virus-treated cells (39.676.91) did (Figure 4) . Only 54.8% of rAd-ODC/ Ex3as-infected cells invaded compared with the rAd-GFP-infected cells.
Antitumorigenic effect of rAd-ODC/Ex3as in nude mouse xenograft model
The potential antitumorigenicity of rAd-ODC/Ex3as was evaluated by using a PC-3 xenograft model in nude mice. Expression of antisense ODC inhibited the growth of PC-3 cells in vivo, as evidenced by the reduction in tumor 
Discussion
Polyamines are aliphatic cations with multiple functions and are essential for life. In normal cells, polyamine levels are intricately controlled by biosynthetic and catabolic enzymes. Multiple abnormalities in the control of polyamine synthesis, metabolism, uptake and function might be responsible for increased levels of polyamines in cancer cells as compared to that of normal cells. Polyamine concentration is higher in the prostate than in most other tissues in the body, making inhibitors of polyamine synthesis enticing prevention agents for prostate cancer. 9 At the same time, targeting specific molecules in cells by antisense inhibition was shown to have potential effectiveness in decreasing the protein expression. ODC is the most important enzyme in polyamine biosynthesis. More recently, the overexpression of ODC in NIH 3T3 cells caused transformation of these cells to a malignant phenotype, in essence qualifying ODC as an oncogene. 23 Inhibition of ODC by DFMO could compromise cell growth and transformation. 24 Schipper's recent in vitro studies using conformationally restricted polyamine analogues showed that these compounds inhibited cell growth, probably by inducing antizyme-mediated degradation of ODC. 25 In addition, Bello-Fernandez et al 26 showed that ODC was a well-defined target gene for c-myc and other oncogenes. Therefore, we targeted the ODC by using an antisense gene delivery strategy with a replication-deficient recombinant Ad vector. In the present study, we demonstrated that rAd-ODC/Ex3as could inhibit prostate cancer growth and lower the invasion of PC-3 cell line.
To acquire a good result on inhibition of ODC synthesis, firstly we scanned different sequences complementary to ODC mRNA by eukaryotic expression vector pcDNA3.1 in PC-3 cells. Sequences approximately 100 nucleotides in length that were complementary to regions spanning the 5 0 -untranslated region, 3 0 -untranslated region, the sixth extron region and the initiation codon region of ODC mRNA were tested for their ability to inhibit translation of ODC. Compared to other groups, the sequence complementary to the initiation codon region had a strong reduction of ODC synthesis. This result was also in accordance with what Madhubala's experiment had proved by oligodeoxynucleotides. 27 According to this, we constructed and packaged the recombinant adenovirus rAd-ODC/Ex3as, which expressed the mRNA complementary to initiation codon of ODC. We demonstrated that the expression of antisense ODC in prostate cancer cells markedly inhibited cell growth in vitro and in vivo, whereas the control did not possess strong antitumor activity. In these experiments, LNCap cells were more sensitive to rAd- 28 which make the change of ODC expression obvious in LNCap cells; secondly, LNCap cell line in itself is easy to be infected by adenovirus, 29 and our experiments also found that the percentage of GFPpositive cells were 66 and 75% in PC-3 and LNCap cells after infected with rAd-GFP at an MOI of 50 and 25, respectively. At the same time, Western blotting showed that 45 and 59% of ODC protein expression were inhibited in PC-3 and LNCap cells infected with rAd-ODC/Ex3as. On the other hand, a substantial decrease in ODC expression resulted in the reduction of polyamine biosynthesis. The relative low level of polyamines shown by HPLC may be the result of diminished ODC expression. In addition, the reduction of polyamines may contribute to the marked suppression of cancer cell growth and tumor formation.
The mechanism underlying the growth inhibition may be accounted for in part by the cell cycle arrest of prostate cancer cells followed by a reduction in polyamine pools. Previous studies had demonstrated that cancer cells underwent cytostasis in the presence of DFMO and this growth arrest could be prevented by the treatment of cells with putrescine. 30 Recent studies also showed that polyamine analogue N 1 ,N 11 -diethylnorspermine also led to a retardation of S-phase progression. 31 This suggestion was supported by the data showing that treatment of PC-3 and LNCap cells with rAd-ODC/ Ex3as caused cell cycle arrest in the G1 phase compared with the control. In addition, our data suggested a regulatory role for antisense ODC in PC-3 cell invasion. The number of invasive cells in rAd-ODC/Ex3as-treated group was 19.478.79, which was far less than that of other groups. As LNCap cell line in essence has little invasion, the Matrigel assay was only carried out in PC-3 Although many details must be demonstrated in its antitumor effect, adenoviral vector-mediated antisense ODC provides rapid and high-level expression and therefore is an option for prostate cancer gene therapy. However, it is known that adenoviral delivery of genes is transient and to last for only 4-6 weeks. Next our lab has paid next attention to using a long-term gene transfer vector, such as a lentiviral vector or modifying vectors with a prostate-specific promoter to infect specifically prostate cancer cells.
